🇺🇸 FDA
Pipeline program

LZRSE-Col7A1 Engineered Autologous Epidermal Sheets

SU-10202010-7130

Phase 2 mab completed

Quick answer

LZRSE-Col7A1 Engineered Autologous Epidermal Sheets for Epidermolysis Bullosa Dystrophica is a Phase 2 program (mab) at ABEONA THERAPEUTICS INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ABEONA THERAPEUTICS INC.
Indication
Epidermolysis Bullosa Dystrophica
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials